MUTZ-3 cells were challenged with different chemicals and mixtures to assess immunotoxic reactions such as skin sensitization on the antigen-presenting cell level.
Nine ovarian cancer cell lines were analyzed using phosphoproteomics and proteomics. The KURAMOCHI cell line was further subjected to treatment with the drug C26A6 and transfection with siRNA towards MTDH and SND1.